Clinicians have always wanted to know if additional IV fluid will improve perfusion. To aid clinicians and physicians in treading the narrow line between supplying beneficial IV fluids and overloading patients with the same, Cheetah Medical developed a fluid management technology that looks beyond the obvious signs and assesses the effect of fluid on patients in critical situations. For helping clinicians manage their patient’s fluid status, the company has devised hemodynamic monitoring systems that leverage a proprietary algorithm to calculate hemodynamic parameters for assessing fluid responsiveness. This assessment enables medical professionals to understand a patient’s unique volume requirements to maintain optimal fluid volume and perfusing critical organs. This is especially critical for septic patients.
Sepsis is a global health priority and the leading cause of death in the US. The average cost per hospital stay for sepsis is $18,600, which is double the average cost per stay across all other conditions. Recently, CMS has updated the SEP-1 bundle, a quality measure stipulating a protocol for the treatment of severe sepsis or septic shock patients.
The non-invasive nature of our FDA-approved device sets it apart from other players in the market by measuring the flow of blood directly from the heart
Cheetah Medical’s technology provides accurate information about the effect of IV fluids on patients in the ICU, emergency departments, RRTs, and operating theatres. It comprises four disposable sensors applied to the patient’s thorax, two each above and below the heart, and plugged in a monitor to display a patient’s hemodynamic profile. The monitor displays information on cardiac output, heart rate, stroke volume, and other key parameters based on a dynamic assessment of the patient using a passive leg raise or fluid bolus.
Once the patient is identified as fluid-responsive or non-responsive, the future course of treatment can be planned. “The non-invasive nature of our FDA-approved device sets it apart from other players in the market by measuring the flow of blood directly at the thorax,” explains Shane Cooke, Chief Strategy Officer of Cheetah Medical. In addition, the disposable sensors can be positioned either on the front or back of the patient, as per convenience. The device’s newly launched customizable user interface can accommodate different patient populations, care settings, and situations.
The Cheetah Medical device is used in over 500 hospitals in the U.S. and 30 countries across the globe. “We aim to offer all patients, especially those in danger of sepsis, with optimal fluid management, in our journey to become the standard of care for fluid management in hospitals,” concludes Cooke.